Oculocerebrofacial syndrome, Kaufman type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2707OMIM:244450Q87.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculocerebrofacial syndrome, Kaufman type (also known as Kaufman oculocerebrofacial syndrome) is an extremely rare genetic disorder characterized by a combination of ocular (eye), cerebral (brain), and facial abnormalities. The condition was first described by Kaufman and colleagues and presents at birth or early infancy with distinctive craniofacial features including microcephaly (abnormally small head), blepharophimosis or narrow palpebral fissures (small eye openings), a thin upper lip, upslanting palpebral fissures, and micrognathia (small jaw). Additional facial features may include a long philtrum and ear anomalies. Neurological involvement is a prominent feature of this syndrome, with affected individuals typically demonstrating severe intellectual disability, hypotonia (reduced muscle tone), and developmental delay. Ocular abnormalities may include microcornea and other structural eye defects. Some patients may also present with respiratory difficulties, feeding problems in infancy, and postnatal growth retardation. Structural brain anomalies have been reported in some cases. There is currently no specific cure or targeted treatment for Kaufman oculocerebrofacial syndrome. Management is supportive and symptomatic, focusing on addressing individual clinical manifestations. This may include physical therapy and developmental support for motor and cognitive delays, ophthalmologic care for eye abnormalities, and nutritional support for feeding difficulties. The condition has been associated with mutations in the UBE3B gene, which plays a role in the ubiquitin-proteasome pathway. Genetic counseling is recommended for affected families.

Clinical phenotype terms— hover any for plain English:

Long footHP:0001833Flat occiputHP:0005469Abnormal lip morphologyHP:0000159Abnormal upper lip morphologyHP:0000177
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Oculocerebrofacial syndrome, Kaufman type.

View clinical trials →

No actively recruiting trials found for Oculocerebrofacial syndrome, Kaufman type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Oculocerebrofacial syndrome, Kaufman type community →

No specialists are currently listed for Oculocerebrofacial syndrome, Kaufman type.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Oculocerebrofacial syndrome, Kaufman type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Oculocerebrofacial syndrome, Kaufman typeForum →

No community posts yet. Be the first to share your experience with Oculocerebrofacial syndrome, Kaufman type.

Start the conversation →

Latest news about Oculocerebrofacial syndrome, Kaufman type

No recent news articles for Oculocerebrofacial syndrome, Kaufman type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Oculocerebrofacial syndrome, Kaufman type

What is Oculocerebrofacial syndrome, Kaufman type?

Oculocerebrofacial syndrome, Kaufman type (also known as Kaufman oculocerebrofacial syndrome) is an extremely rare genetic disorder characterized by a combination of ocular (eye), cerebral (brain), and facial abnormalities. The condition was first described by Kaufman and colleagues and presents at birth or early infancy with distinctive craniofacial features including microcephaly (abnormally small head), blepharophimosis or narrow palpebral fissures (small eye openings), a thin upper lip, upslanting palpebral fissures, and micrognathia (small jaw). Additional facial features may include a lo

How is Oculocerebrofacial syndrome, Kaufman type inherited?

Oculocerebrofacial syndrome, Kaufman type follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Oculocerebrofacial syndrome, Kaufman type typically begin?

Typical onset of Oculocerebrofacial syndrome, Kaufman type is neonatal. Age of onset can vary across affected individuals.